SCI时时刷

search
+
Novel therapies leading to a new landscape in gynecologic tumors
Novel therapies leading to a new landscape in gynecologic tumors
In the past decade, we have witnessed notable advances in gynecologic cancer research, from the laboratory to the clinic, ...
Outcomes and endpoints of relevance in gynecologic cancer clinical trials
Outcomes and endpoints of relevance in gynecologic cancer clinical trials
Gynecologic cancers are a major cause of morbidity and mortality despite recent advances in oncology drug development, and...
Update in the molecular classification of endometrial carcinoma
Update in the molecular classification of endometrial carcinoma
INTRODUCTIONThe molecular endometrial carcinoma classification introduced by The Cancer Genome Atlas (TCGA) has elicited a...
Biomarker-driven therapy in endometrial cancer
Biomarker-driven therapy in endometrial cancer
dMMR/MSI-H endometrial cancer is characterized by loss of DNA mismatch repair and high mutation rates. This subtype accoun...
Immunotherapy in endometrial cancer
Immunotherapy in endometrial cancer
IntroductionEndometrial cancer is the most common gynecologic cancer. In the US, approximately 66 570 new cases of uterine...
Overcoming PARP inhibitor resistance in ovarian cancer
Overcoming PARP inhibitor resistance in ovarian cancer
IntroductionOvarian cancer (OC) is a leading cause of cancer death among women worldwide, being the most lethal tumor of t...
Genomic testing in high-grade serous ovarian cancer: current options and future development
Genomic testing in high-grade serous ovarian cancer: current options and future development
DNA Damage Repair DeficiencyAround half of all high-grade serous ovarian cancers have defects in genes related to the norm...
New therapies for clear cell ovarian carcinoma
New therapies for clear cell ovarian carcinoma
IntroductionOvarian clear cell carcinoma is a rare subtype of epithelial ovarian cancer, accounting for 5–11% of total epi...
Novel therapeutics in low-grade serous ovarian cancer
Novel therapeutics in low-grade serous ovarian cancer
Histology and Molecular BiologyHistorically, serous ovarian cancer was classified as grade 1, 2, or 3.3 With the seemingly...
Advances in immunotherapy in cervical cancer
Advances in immunotherapy in cervical cancer
INTRODUCTION AND BIOLOGICAL RATIONALE OF IMMUNOTHERAPY IN CERVICAL CANCERCervical cancer is the fourth most frequently dia...
Updates on cervical cancer prevention
Updates on cervical cancer prevention
Primary prevention: human papillomavirus vaccinationVaccine DevelopmentHuman papillomaviruses (HPV) are small non-envelope...
Integrating antibody drug conjugates in the management of gynecologic cancers
Integrating antibody drug conjugates in the management of gynecologic cancers
IntroductionThe American Cancer Society estimates that 115 130 new cases of gynecological cancer arose in 2022, causing 32...
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy
INTRODUCTIONGestational trophoblastic neoplasia comprises an infrequent group of malignancies encompassing invasive moles,...
Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR)
Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR)
Gynecological malignancies affect women in low- and middle-income countries at disproportionately higher rates compared wi...
Transvaginal ultrasound-guided biopsy in patients with suspicious primary advanced tubo-ovarian carcinoma
Transvaginal ultrasound-guided biopsy in patients with suspicious primary advanced tubo-ovarian carcinoma
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire
Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire
WHAT IS ALREADY KNOWN ON THIS TOPICHOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICYINTRODUCTIONAccording to the Wo...
Healthcare associated infections in gynecologic oncology: clinical and economic impact
Healthcare associated infections in gynecologic oncology: clinical and economic impact
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Patient-reported symptoms at discharge and risk of complications after gynecologic surgery
Patient-reported symptoms at discharge and risk of complications after gynecologic surgery
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Endometrial carcinosarcoma
Endometrial carcinosarcoma
HIGHLIGHTSEndometrial carcinosarcoma is a high-grade endometrial carcinoma with secondary sarcomatous de-differentiation.A...
Best original research presented at the 23rd European Congress on Gynaecological Oncology--Best of ESGO 2022
Best original research presented at the 23rd European Congress on Gynaecological Oncology--Best of ESGO 2022
Best of ESGO 2022 includes a selection of best original research presented during the 23rd European Congress on Gynaecolog...
Impact of podcasting on novel and conventional measures of academic impact
Impact of podcasting on novel and conventional measures of academic impact
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Locoregional therapy for oligometastatic cervical cancer: a single-center retrospective study
Locoregional therapy for oligometastatic cervical cancer: a single-center retrospective study
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Minimally invasive versus open pelvic exenteration in gynecological malignancies: a propensity-matched survival analysis
Minimally invasive versus open pelvic exenteration in gynecological malignancies: a propensity-matched survival analysis
Summary of Main ResultsIn our study there was no difference in disease-free survival or cancer-specific survival between p...
Avascular spaces in radical hysterectomy
Avascular spaces in radical hysterectomy
The most common cancer in women worldwide is cervical cancer. For early-stage disease the standard treatment is radical hy...
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
INTRODUCTIONEndometrial carcinoma is the sixth most commonly diagnosed cancer in women worldwide, with increasing incidenc...
Stepwise demonstration of laparoscopic excision of enlarged lymph nodes at the level of the right iliac vessels
Stepwise demonstration of laparoscopic excision of enlarged lymph nodes at the level of the right iliac vessels
SummaryOur aim was to provide a stepwise demonstration of laparoscopic excision of enlarged lymph nodes at the level of th...
Growing teratoma syndrome
Growing teratoma syndrome
A 33-year-old woman with a diagnosis of high-grade mixed germ cell tumor including immature teratoma and yolk sac tumor pr...
Ileo-jejunal gastrointestinal stromal tumor (GIST) mimicking an ovarian mass
Ileo-jejunal gastrointestinal stromal tumor (GIST) mimicking an ovarian mass
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
阅读更多
format_indent_increase